TH International (THCH) had the highest return between August 15, 2022 and December 31, 2022 by a US stock, returning 2,316,566.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
TH International (THCH) | 8/15/2022 - 12/31/2022 | 2,316,566.67% |
Digital Brands (DBGIW) | 8/15/2022 - 12/31/2022 | 2,563.12% |
ENDRA Life Sciences (NDRA) | 8/15/2022 - 12/31/2022 | 1,059.45% |
Reviva Pharmaceuticals (RVPHW) | 8/15/2022 - 12/31/2022 | 874.41% |
Hudson Acquisition I Corp Right (HUDAR) | 8/15/2022 - 12/31/2022 | 628.57% |
Cabaletta Bio (CABA) | 8/15/2022 - 12/31/2022 | 500.65% |
Reviva Pharmaceuticals (RVPH) | 8/15/2022 - 12/31/2022 | 498.59% |
Indivior PLC Ordinary Shares (INDV) | 8/15/2022 - 12/31/2022 | 484.68% |
Nine Energy Service (NINE) | 8/15/2022 - 12/31/2022 | 404.51% |
ProQR Therapeutics (PRQR) | 8/15/2022 - 12/31/2022 | 326.37% |
Akero Therapeutics (AKRO) | 8/15/2022 - 12/31/2022 | 317.36% |
Ucloudlink (UCL) | 8/15/2022 - 12/31/2022 | 307.37% |
NWTN Inc Warrant (NWTNW) | 8/15/2022 - 12/31/2022 | 301.94% |
Madrigal Pharmaceuticals (MDGL) | 8/15/2022 - 12/31/2022 | 300.51% |
Summit Therapeutics (SMMT) | 8/15/2022 - 12/31/2022 | 289.91% |
Pyxis Tankers (PXSAW) | 8/15/2022 - 12/31/2022 | 282.75% |
GlycoMimetics (GLYC) | 8/15/2022 - 12/31/2022 | 251.88% |
Enliven Therapeutics (ELVN) | 8/15/2022 - 12/31/2022 | 249.57% |
Terns Pharmaceuticals (TERN) | 8/15/2022 - 12/31/2022 | 243.92% |
Biovie (BIVI) | 8/15/2022 - 12/31/2022 | 237.83% |
Heartbeam (BEAT) | 8/15/2022 - 12/31/2022 | 225.33% |
Immunovant (IMVT) | 8/15/2022 - 12/31/2022 | 220.98% |
Studio City International (MSC) | 8/15/2022 - 12/31/2022 | 213.68% |
Ardelyx (ARDX) | 8/15/2022 - 12/31/2022 | 209.78% |
NLS Pharmaceutics (NLSP) | 8/15/2022 - 12/31/2022 | 200% |
